Acute rhabdomyolysis in a young woman with moderate COVID-19
Kohei Fujita,
Osamu Kanai,
Kazutaka Nanba,
Naoki Esaka,
Hiroaki Hata,
Koichi Seta,
Takao Odagaki
Affiliations
Kohei Fujita
Department of Infectious Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan; Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan; Corresponding author at: Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, 1-1, Fukakusa-Mukaihata, Fushimi, Kyoto, 612-8555, Japan.
Osamu Kanai
Department of Infectious Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan; Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
Kazutaka Nanba
Department of Infectious Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan; Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
Naoki Esaka
Department of Infectious Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan; Department of Gastroenterology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
Hiroaki Hata
Department of Infectious Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan; Department of Surgery, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
Koichi Seta
Department of Infectious Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan; Department of Nephrology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
Takao Odagaki
Department of Infectious Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is having serious medical, social, and economic impacts worldwide. COVID-19 may lead to a variety of complications, including rhabdomyolysis. Although rhabdomyolysis is a rare complication, it can lead to severe kidney damage. Recent studies suggest that rhabdomyolysis caused by SARS-CoV-2 is more common in middle-aged and older men with severe COVID-19. Herein we report a case of rhabdomyolysis in a young woman with moderate COVID-19. She had a habit of muscle training. She presented with moderate COVID-19 and acute rhabdomyolysis that required a large volume of fluid infusion in addition to dexamethasone and remdesivir. Clinicians should pay attention to the development of rhabdomyolysis in patients with COVID-19, especially those with a habit of strenuous exercise or muscle training, even if they are young and have moderate COVID-19.
